Although FGFR3 mutation presumably initiated cancer development in these cancers, it has been suggested that at some point during tumor progression, EGFR signaling may have increased to a level where it repressed mutant FGFR3 expression and dominated the downstream signaling [159]. Here, EGFR is linked to cancer.